Skip to main content
EXO • RESEARCH USE ONLY

Exosomes

Nano-sized extracellular vesicles secreted by mesenchymal stem cells derived from human umbilical cord tissue. They carry signaling molecules including growth factors, cytokines, mRNAs, and miRNAs that modulate cellular processes. Umbilical cord tissue MSC-derived exosomes are associated with an immune-privileged origin, robust paracrine signaling, and regenerative potency, with a cell-free profile that avoids tumorigenicity and immune rejection risks tied to some cell-based approaches. Their profile includes anti-inflammatory, anti-fibrotic, and pro-angiogenic properties.

Product image for Exosomes derived from umbilical cord tissue MSCs
Nano-EV · RNA-rich
MSC-UCT CARGO
— Extracellular vesicles loaded with growth factors, cytokines, mRNAs, and miRNAs that recapitulate MSC paracrine instruction without delivering intact donor cells.
Anti-fibrotic · pro-angiogenic
FUNCTIONAL PHENOTYPE
— Immune-privileged cord origin paired with anti-inflammatory, anti-fibrotic, and pro-angiogenic signaling relevant to broad regenerative research.
Cell-free alternative
RISK PROFILE
— Discussed as capturing regenerative potency while sidestepping tumorigenicity and immune-rejection concerns tied to some live-cell transplant paradigms.
ROUTES, FORMATS & APPLICATIONS
Routes
IVIntravenousIMIntramuscularINIntranasalSQSubcutaneous
Quantities
400 Billion Exosomes1ml
1200 Billion Exosomes3ml
Potential Applications

These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.

  • Rheumatoid Arthritis
  • Psoriasis
  • Multiple Sclerosis (MS)
  • Systemic Lupus Erythematosus (SLE)
  • Crohn's Disease
  • Celiac Disease
  • Ulcerative Colitis
  • Type 1 & Type 2 Diabetes
  • Fibromyalgia
  • Chronic Inflammation
  • Chronic Kidney Disease
  • COPD / Pulmonary Fibrosis
  • Liver Failure
  • Skin Rejuvenation / Wrinkles / Aging
  • Hair Loss (Alopecia)
  • Intervertebral Disc Degeneration
  • COVID-19 Pneumonia
  • Graft-versus-host disease (GvHD)
  • Erectile Dysfunction
  • Musculoskeletal Injuries
  • Systemic inflammation & nerve regeneration
  • IBD weight-loss protection; elastin synthesis / wound healing
MECHANISM & ORIGIN

MSC-Derived Paracrine Signaling

These exosomes are nano-sized extracellular vesicles from umbilical cord tissue MSCs, carrying growth factors, cytokines, mRNAs, and miRNAs. They reflect immune-privileged origin, robust paracrine signaling, and regenerative potency without the tumorigenicity or immune rejection risks tied to some cell therapies.

Broad molecular cargo
Includes growth factors, cytokines, mRNAs, and miRNAs that modulate recipient cell behavior.
Anti-inflammatory, anti-fibrotic, pro-angiogenic
Documented profile supporting repair and remodeling research pathways.
Cell-free administration
Therapeutic benefits are discussed relative to risks associated with some cell-based therapies, such as tumorigenicity or immune rejection.

Compliance · Exosomes

cGMP manufacturing & cryopreservation

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY
Viability & cryopreservation

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More

Keep browsing our product lineup